ACUC.ST
Price:
$0.745
Market Cap:
$159.81M
AcuCort AB (publ) develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions. It offers Zeqmelit, a medicine used for the treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting, as well as for the treatment of COVID-19 patients who need supplemental oxygen treatment. AcuCort AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-04-24
Stock Exchange
STO
Ticker
ACUC.ST
According to AcuCort AB’s latest financial reports and current stock price. The company's current ROE is -37.21%. This represents a change of 278.71% compared to the average of -9.83% of the last 4 quarters.
The mean historical ROE of AcuCort AB over the last ten years is -22.59%. The current -37.21% ROE has changed 64.71% with respect to the historical average. Over the past ten years (40 quarters), ACUC.ST's ROE was at its highest in in the December 2021 quarter at -5.06%. The ROE was at its lowest in in the December 2024 quarter at -18.36%.
Average
-22.59%
Median
-18.75%
Minimum
-42.59%
Maximum
-8.25%
Discovering the peaks and valleys of AcuCort AB ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 89.82%
Maximum Annual ROE = -8.25%
Minimum Annual Increase = -36.67%
Minimum Annual ROE = -42.59%
Year | ROE | Change |
---|---|---|
2024 | -42.59% | 47.87% |
2023 | -28.80% | -11.22% |
2022 | -32.45% | 73.01% |
2021 | -18.75% | 11.57% |
2020 | -16.81% | 8.38% |
2019 | -15.51% | -36.67% |
2018 | -24.49% | 56.32% |
2017 | -15.67% | 89.82% |
The current ROE of AcuCort AB (ACUC.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-34.61%
5-year avg
-27.88%
10-year avg
-22.59%
AcuCort AB’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AcuCort AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AcuCort AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AcuCort AB's ROE?
How is the ROE calculated for AcuCort AB (ACUC.ST)?
What is the highest ROE for AcuCort AB (ACUC.ST)?
What is the 3-year average ROE for AcuCort AB (ACUC.ST)?
What is the 5-year average ROE for AcuCort AB (ACUC.ST)?
How does the current ROE for AcuCort AB (ACUC.ST) compare to its historical average?